Get the Daily Brief
Latest Biotech News
UniQure’s Gene Therapy Slows Huntington’s Disease Progression Significantly
UniQure’s gene therapy candidate AMT-130 demonstrated a striking 75% slowing of Huntington’s disease progression in a 36-month Phase I/II study involving patients in the US and Europe. These...
RSV Vaccines Confirmed Safe and Effective by Cochrane Review
A comprehensive Cochrane systematic review analyzing data from 14 randomized clinical trials including over 100,000 participants globally confirms that respiratory syncytial virus (RSV) vaccines...
Novel Radioligand Combo Therapy Shows Promise in Recurrent Prostate Cancer
Clinical trials led by UCLA Health’s Jonsson Comprehensive Cancer Center demonstrate that combining PSMA-targeted radioligand therapy with stereotactic body radiotherapy more than doubles...
Softgel and Lipid-Based Formulations Enhance Drug Performance
Catalent’s advanced softgel technologies, including lipid-based formulations and emerging plant-based gelatin alternatives, are providing biopharma clients with enhanced options to optimize drug...
Sanofi Ventures Injects $625 Million to Fuel Early-Stage Biotech Innovation
Sanofi Ventures announced a $625 million capital infusion, increasing its total assets under management to over $1.4 billion. This significant investment aims to back early-stage biotech startups...
Tirzepatide Shows Robust Weight Loss Benefits Across Populations
An international meta-analysis has highlighted tirzepatide, a dual GIP and GLP-1 receptor agonist, as an effective agent for weight management in both diabetic and non-diabetic patients. The...
Advanced AI Models Illuminate Protein Language for Better Predictions
Researchers at MIT applied sparse autoencoders to protein language models (PLMs), making these complex AI tools more interpretable by revealing underlying patterns related to protein families and...
Novel Blood Test Accurately Predicts Risk of Severe Liver Disease
Karolinska Institutet researchers introduced the CORE risk score, a simple blood-based test that predicts individuals at high risk for severe liver diseases. Published in The BMJ, this novel...
Engineering Macrophages Enhances Precision Immunotherapy in Melanoma
A transformative study published in the Journal of Translational Medicine demonstrates the engineering of macrophages to augment immunotherapy efficacy against melanoma. These modified immune...
uniQure's Huntington’s Therapy Data Sparks Stock Surge
uniQure announced striking 36-month clinical data from its Phase I/II AMT-130 gene therapy trial for Huntington’s disease, reporting a 75% slowdown in disease progression at high dose among...
Prostate Cancer: Radiopharmaceutical Plus SBRT Shows Promise
Clinical researchers reported encouraging Phase II trial results combining a radiopharmaceutical agent with stereotactic body radiation therapy (SBRT) for oligometastatic recurrent prostate...
RSV Vaccine Safety and Efficacy Confirmed by Cochrane Review
A systematic review pooling data from 14 randomized trials involving over 100,000 participants confirms both safety and efficacy of respiratory syncytial virus (RSV) vaccines. Published in the...
Sanofi Boosts Venture Capital with Major $625M Injection
Sanofi Ventures received a $625 million capital infusion, elevating its assets under management to over $1.4 billion. This strategic funding aims to accelerate early-stage biotech startups...
AI Transparency Advances: Protein Language Models Demystified
Researchers at MIT applied sparse autoencoders to protein language models (PLMs) to clarify how these AI systems predict protein function from amino acid sequences. This approach enhances...
Thyme Care Raises $97M to Advance Value-Based Oncology Services
Thyme Care secured $97 million in a Series D funding round led by prominent investors including CVS Health Ventures, Foresite Capital, Morgan Health, and Humana, bringing total raised to $275...
Hypnosis Improves Compliance with Ventilation Masks in Respiratory Failure
A novel pilot study presented at the European Emergency Medicine Congress demonstrated that hypnosis significantly enhances patient comfort and compliance during non-invasive ventilation for acute...
AggreBots: Living Lung Cell Robots Engineered for Targeted Therapy
A team at Carnegie Mellon University introduced 'AggreBots,' microscale living robots fabricated from human lung cells capable of customizable motility. Published in Science Advances, this tissue...
Tirzepatide Demonstrates Broad Weight Reduction Benefits
An international systematic review and meta-analysis revealed that tirzepatide, a dual GIP and GLP-1 receptor agonist, achieves significant weight loss across patient groups with and without...
Novel Genomic Insights into Banana Blood Disease Resistance Discovered
Through transcriptomic analysis, researchers identified key genes associated with resistance to banana blood disease, a critical threat to global banana cultivation. This study provides molecular...
UniQure Gene Therapy Slows Huntington’s Progression – Shares Hit Five-Year High
UniQure’s AMT-130 gene therapy has demonstrated a significant 75% slowing in Huntington’s disease progression in a pivotal 36-month Phase I/II trial. Data from US and European studies reveal...